PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Pupil response may shed light on who responds best to transcranial magnetic stimulation for depression

Two new studies from UCLA Health suggest that the “window to the soul” may give a glimpse into the brain in depression

2023-10-20
(Press-News.org) New findings from researchers at UCLA Health suggest that measuring changes in how pupils react to light could help predict recovery from depression and personalize transcranial magnetic stimulation (TMS) treatment of major depressive disorder.

TMS is a safe, non-invasive therapy that uses magnetic fields to stimulate parts of the brain involved in mood regulation. While TMS is proven effective, not all patients respond equally well to the therapy. The ability to predict who will benefit most could allow doctors to better customize and target treatments.

In two recent studies, UCLA scientists found that the pupil’s response to light before treatment correlated with improvements in depression symptoms over the course of therapy. Pupil size reflects activation of the autonomic nervous system, which controls involuntary functions and is negatively impacted in people with depression.

The first study, appearing in the Journal of Affective Disorders, reports on outcomes for 51 patients who underwent daily TMS sessions. Before receiving treatment, researchers measured the patients' baseline pupillary constriction amplitude, or CA: how much the pupil shrinks when exposed to light. The pupil’s constriction is an indicator of parasympathetic nervous system function. The researchers found a significant association between baseline pupil constriction amplitude and symptom improvement, indicating that a greater constriction amplitude at baseline was associated with a better outcome. In other words, those with larger pupil constriction in response to light at baseline showed greater symptom improvement over their full treatment.

The second study, appearing in Brain Stimulation, went further and compared patients who were treated for depression with one of two common TMS protocols: 10 Hz stimulation and intermittent theta burst stimulation (iTBS). In 10 Hz stimulation, magnetic pulses are delivered at a fixed rate of 10 pulses per second, or 10 Hz, a continuous and relatively high-frequency stimulation. iTBS is a faster form of stimulation with bursts of three pulses at 50 Hz, repeated with short breaks between bursts. This pattern is thought to mimic the natural rhythm of certain brain activities.

The researchers found that people with slower pupillary constriction had significantly greater improvement in depression after 10 sessions if they received iTBS rather than 10 Hz treatment.

"These results suggest we may be able to use a simple test of the pupil to identify who is most likely to respond to electromagnetic stimulation of the brain to treat their depression," said researcher Cole Citrenbaum, lead author of both studies and a researcher with the TMS Clinical and Research Program at the Semel Institute for Neuroscience and Human Behavior at UCLA.

The researchers propose that measuring pupillary reactivity before starting TMS could eventually help guide treatment selection on an individual basis. “Additionally, we may be able to tailor the frequency of stimulation to the individual patient to maximize their benefit from treatment,” Citrenbaum said. This personalized approach could lead to better outcomes for patients.

"At the present time, about 65% of patients treated with TMS have a substantial improvement in their depression,” said Dr. Andrew F. Leuchter, senior author of both studies and Distinguished Professor of Psychiatry at the Jane and Jerry Semel Institute for Neuroscience and Human Behavior at UCLA. "Our goal is to have more than 85% of patients fully recover from depression. As we better understand the complex brain activity underlying depression, we move closer to matching patients with the treatments that ensure their full recovery. Pupil testing may be one useful tool in reaching this goal."

The studies add to growing evidence on the benefits of biologically-based personalization in treating major depression. UCLA researchers plan further trials to confirm the value of pupillometry in optimizing transcranial magnetic stimulation.

Articles:

Pretreatment pupillary reactivity is associated with outcome of Repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder (MDD) Citrenbaum et al. Journal of Affective Disorders, Volume 339, 2023, Pages 412-417, ISSN 0165-0327, https://doi.org/10.1016/j.jad.2023.07.008.

Pretreatment pupillary reactivity is associated with differential early response to 10 Hz and intermittent theta-burst Repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder (MDD). Citrenbaum et al. Brain Stimulation, 2023, ISSN 1935-861X, https://doi.org/10.1016/j.brs.2023.10.006.

END


ELSE PRESS RELEASES FROM THIS DATE:

Women with a heart healthy diet in midlife are less likely to report cognitive decline later

2023-10-20
Women with diets during middle age designed to lower blood pressure were about 17 percent less likely to report memory loss and other signs of cognitive decline decades later, a new study finds. Led by researchers from NYU Grossman School of Medicine, the new findings suggest that a mid-life lifestyle modification – adoption of the Dietary Approaches to Stop Hypertension, or DASH diet – may improve cognitive function later in life for women, who make up more than two-thirds of those diagnosed with Alzheimer’s disease, the most prevalent form of dementia. The findings, published online today in ...

Recognizing excellence in endocrinology, ESE announces the winners of its prestigious Awards for 2024

2023-10-20
The  winners of the Society’s prestigious annual Awards for 2024 have all contributed to improving knowledge and expertise in endocrinology and have helped drive innovation and progression across the field. Each of these deserving winners will be presenting a plenary lecture at ESE’s annual Congress, the European Congress of Endocrinology (ECE) 2024, which will be held in Stockholm, Sweden from 11-14 May 2024. The 2024 Geoffrey Harris Award is being presented to Jens C. Brüning (Germany). This Award recognises outstanding researchers in the field of neuroendocrinology. Jens Brüning is the Director of the Max Planck Institute for Metabolism Research ...

Deep dive into the gut unlocks new disease treatments

Deep dive into the gut unlocks new disease treatments
2023-10-20
The more diverse species in your gut, the better it is for your health. Now an international team led by the Hudson Institute of Medical Research has found a way to determine which species are important and how they interact to create a healthy microbiome. Understanding these relationships opens the door to a new world of medical opportunities for conditions from Inflammatory Bowel Disease to infections, autoimmune diseases and cancers. Associate Professor Samuel Forster and his team at Hudson Institute of Medical Research, working with collaborators from the Institute for Systems Biology in ...

Felix Beuschlein announced as winner of 2024 Transatlantic Alliance Award in Endocrinology

Felix Beuschlein announced as winner of 2024 Transatlantic Alliance Award in Endocrinology
2023-10-20
Felix Beuschlein is Professor of Internal Medicine/Endocrinology and Director of the Clinic for Endocrinology, Diabetology and Clinical Nutrition at the University Clinic Zurich in Switzerland. He received his medical degree from School of Medicine at the University of Würzburg and completed his medical training in Freiburg, both in Germany. For postdoctoral studies he joined the University of Michigan in Ann Arbor. Following a professorship for Endocrine Research at the University of Munich, he was elected for a chair position at the University of Zurich in 2017.   The Transatlantic ...

Partnership looks to the stars to improve cybersecurity

2023-10-20
   A new partnership between Edith Cowan University (ECU), observation data company QL Space, and University of South Wales (UK) is looking to the stars, literally, to create more secure and efficient communication.     The collaboration will focus on ‘free space optics’, which uses light all around we can’t see to communicate, by sending data via light particles, or photons.      ECU School of Science Senior Lecturer Dr Shihao Yan said this brought with it many benefits compared to using radio frequencies to send information.     “When ...

Electric hair styling products common cause of burn injuries in children

2023-10-20
AAP media contacts:           Lisa Black, 630-626-6084, lblack@aap.org                                                       Tom McPheron, 630-626-6315, tmcpheron@aap.org                                                          ...

Adolescents and young adults of all identities open to discussing sexual identity and gender identity with doctors

2023-10-20
AAP media contacts:           Lisa Black, 630-626-6084, lblack@aap.org Tom McPheron, 630-626-6315, tmcpheron@aap.org Adam Alexander, 630-626-6765, aalexander@aap.org Washington, D.C.— Teenagers and young adults are fairly open to the idea of talking with their doctors and nurses about their sexual orientation and gender identity and are okay being asked through various methods, whether on paper, electronically, or in person, according to research presented during the 2023 AAP National Conference ...

Live streaming platform ‘Twitch’ poses risks for minors who may be manipulated, preyed upon: New research 

2023-10-20
AAP media contacts:         Lisa Black, 630-626-6084, lblack@aap.org  Tom McPheron, 630-626-6315, tmcpheron@aap.org   Adam Alexander, 630-626-6765, aalexander@aap.org    Washington, D.C.— A popular live streaming platform, Twitch, poses risks to minors who can interact with adult strangers and donate money to streamers without the supervision of a parent or guardian, according to research presented during the 2023 AAP National Conference & Exhibition at the Walter E. Washington Convention Center.   The abstract, “Predator Paradise: Analyzing the Ease ...

Father’s postpartum depression doubles child’s odds of adverse childhood experiences before age 5 

2023-10-20
AAP media contacts: Lisa Black, 630-626-6084, lblack@aap.org  Tom McPheron, 630-626-6315, tmcpheron@aap.org                                  Adam Alexander, 630-626-6765, aalexander@aap.org     Washington, D.C.—A father’s depression during his child’s first year of life has been associated with difficulties in parenting and child behavior, but new research finds that it also doubles the odds of a child having three or more adverse childhood experiences ...

Delta-8 and its online availability to minors raises concerns

2023-10-20
For release: 12:01 a.m. ET Friday, Oct. 20, 2023  AAP media contacts: Lisa Black, 630-626-6084, lblack@aap.org  Tom McPheron, 630-626-6315, tmcpheron@aap.org                                  Adam Alexander, 630-626-6765, aalexander@aap.org    WASHINGTON, D.C.-- Delta-8 is a substance that produces a high akin to THC. While THC is a federally banned substance, delta-8 is technically a different chemical and is therefore not federally banned. New research suggests the growing popularity of ...

LAST 30 PRESS RELEASES:

Mapping the Universe, faster and with the same accuracy

Study isolates population aging as primary driver of musculoskeletal disorders

Designing a sulfur vacancy redox disruptor for photothermoelectric and cascade‑catalytic‑driven cuproptosis–ferroptosis–apoptosis therapy

Recent advances in dynamic biomacromolecular modifications and chemical interventions: Perspective from a Chinese chemical biology consortium

CRF and the Jon DeHaan Foundation to launch TCT AI Lab at TCT 2025

Canada’s fastest academic supercomputer is now online at SFU after $80m upgrades

Architecture’s past holds the key to sustainable future

Laser correction for short-sightedness is safe and effective for older teenagers

About one in five people taking Ozempic, Wegovy or Mounjaro say food tastes saltier or sweeter than before

Taking semaglutide turns down food noise, research suggests

Type 2 diabetes may double risk of sepsis, large community-based study suggests

New quantum sensors can withstand extreme pressure

Tirzepatide more cost-effective than semaglutide in patients with knee osteoarthritis and obesity

GLP-1 drugs shown cost-effective for knee osteoarthritis and obesity

Interactive apps, AI chatbots promote playfulness, reduce privacy concerns

How NIL boosts college football’s competitive balance

Moffitt researchers develop machine learning model to predict urgent care visits for lung cancer patients

Construction secrets of honeybees: Study reveals how bees build hives in tricky spots

Wheat disease losses total $2.9 billion across the United States and Canada between 2018 and 2021

New funding fuels development of first potentially regenerative treatment for multiple sclerosis

NJIT student–faculty team wins best presentation award for ant swarm simulation

Ants defend plants from herbivores but can hinder pollination

When the wireless data runs dry

Inquiry into the history of science shows an early “inherence” bias

Picky eaters endure: Ecologists use DNA to explore diet breadth of wild herbivores

Study suggests most Americans would be healthier without daylight saving time

Increasing the level of the protein PI31 demonstrates neuroprotective effects in mice

Multi-energy X-ray curved surface imaging-with multi-layer in-situ grown scintillators

Metasurface enables compact and high-sensitivity atomic magnetometer

PFAS presence confirmed in the blood of children in Gipuzkoa

[Press-News.org] Pupil response may shed light on who responds best to transcranial magnetic stimulation for depression
Two new studies from UCLA Health suggest that the “window to the soul” may give a glimpse into the brain in depression